Dr. Jennifer L. Vickers, MD

Dr. Vickers practices at Sagis Diagnostics - Houston (Directors Row) in Houston, Texas.

Dr. Vickers' NPI, 1184859225, was assigned on May 19, 2009. Dr. Vickers graduated from UTMB Health in 2009. Dr. Vickers holds Texas license P8626.

Dr. Vickers' primary practice is Sagis Diagnostics - Houston (Directors Row), at 4131 Directors Row, Houston, TX 77092. The practice phone is (877) 697-2447.

Dr. Vickers' primary practice is Sagis Diagnostics - Houston (Directors Row) in Houston, Texas. The medical group on file is Sagis Diagnostics. Dmand AI also links Dr. Vickers to 5 more group practices and clinics and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vickers practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Vickers' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Vickers is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Vickers' licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, scalp rash, skin cyst and skin discoloration among the conditions Dr. Vickers treats.

CMS data shows 324 Medicare services from Dr. Vickers across 8 procedure codes in 2024, for 167 Medicare patients. Medicare paid $16,386 for them. Every service was in an office.

CMS counts 167 Medicare patients who saw Dr. Vickers in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vickers' median patient age at 55, with 52% women.

In 2024, Dr. Vickers wrote 126 Medicare Part D claims for 66 patients. 98% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $900 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

Dr. Vickers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 85 procedures of removal of skin lesions by Dr. Vickers, more than 74% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Vickers, published from 2009 to 2016. The most frequent topics are Exanthema and Facial Dermatoses. Dr. Vickers' most frequent co-authors are Brent Christopher Kelly, MD, Bijan Safai, MD and John Charles Howard, DO.

CMS Open Payments shows 292 general payments to Dr. Vickers from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Merz North America, Inc. paid the most, $22,085. It also lists 1 research payment totaling $128 in 2024, naming 1 clinical trial.

Dr. Vickers graduated from UTMB Health in 2009.

Dr. Vickers is in network with 23 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.